Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.16 USD | -0.16% | -6.14% | +77.13% |
05-08 | Transcript : Y-mAbs Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-07 | Earnings Flash (YMAB) Y-MABS THERAPEUTICS Posts Q1 Revenue $19.9M, vs. Street Est of $22.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+77.13% | 534M | |
+7.11% | 113B | |
+11.05% | 106B | |
+0.64% | 22.27B | |
-12.18% | 22.22B | |
-5.38% | 19.43B | |
-37.85% | 17.87B | |
-6.03% | 17.24B | |
+7.88% | 14.29B | |
+34.52% | 12.52B |
- Stock Market
- Equities
- YMAB Stock
- News Y-mAbs Therapeutics, Inc.
- Cowen Downgrades Y-mAbs Therapeutics to Market Perform From Outperform